Keyphrases
Histoplasmosis
100%
Itraconazole
52%
Modern History
50%
Invasive Fungal Infection
47%
Candida Bloodstream Infection
47%
People Living with HIV (PLHIV)
37%
Confidence Interval
31%
United States
30%
Long-term Mortality
28%
All-cause Mortality
24%
Propensity Score Analysis
23%
Intubated Patients
23%
Retrospective Cohort Analysis
23%
Critically Ill
23%
SUBA-itraconazole
23%
Attributable Mortality
23%
COVID-19
23%
Solid Organ Transplant Recipients
23%
Non-HIV Cryptococcal Meningitis
23%
Antifungal Agents
23%
Fed Condition
23%
Coccidioidomycosis
23%
Skin Tissue
23%
Soft Tissue Infection
23%
Internal Validation
23%
Fluconazole Resistance
23%
Geographic Distribution
23%
Infectious Disease Physician
23%
Mycoses
23%
Clinical Prediction Model
23%
Cryptococcal Meningitis
23%
Blastomycosis
23%
Novel Agents
23%
Disease Reporting
23%
Patient Caregivers
23%
Invasive Fungal Disease
23%
Shared Vision
23%
Improved Outcomes
23%
Fungal Diseases
23%
Single Center
23%
Transplant Recipients
23%
Fluconazole
22%
Odds Ratio
18%
Antiretroviral Therapy
16%
Low Risk
15%
Solid Organ Transplant
15%
Novel Antifungals
15%
Retrospective Analysis
15%
Candidemia
14%
Hazard Ratio
13%
Pharmacology, Toxicology and Pharmaceutical Science
Histoplasmosis
76%
Candida
54%
Itraconazole
51%
Systemic Mycosis
47%
Bloodstream Infection
47%
HIV
47%
Diseases
34%
Fluconazole
31%
Infection
30%
Antifungal Agent
27%
Cohort Study
25%
All Cause Mortality
24%
Coronavirinae
23%
Cryptococcal Meningitis
23%
Bioavailability
23%
Side Effect
23%
Aspergillus
10%
Clinical Trial
9%
Candidemia
8%
Immunosuppressive Agent
5%
Pharmacodynamics
5%
Drug-Drug Interaction
5%
Pharmacokinetics
5%
Retrospective Study
5%
Echinocandin
5%
Medicine and Dentistry
Histoplasmosis
47%
Infection
28%
Clinician
27%
Geographic Distribution
23%
Cohort Analysis
23%
Systemic Mycosis
23%
Cryptococcal Meningitis
23%
Dimorphic Fungal Infection
23%
Blastomycosis
23%
COVID-19
23%
Coccidioidomycosis
23%
Human Immunodeficiency Virus
23%
Bloodstream Infection
23%
Mycosis
23%
Fungal Infection
23%
Soft Tissue Infection
23%
All Cause Mortality
9%
Hazard Ratio
8%
Aspergillus
7%
Infectious Disease
7%
Antimicrobial Therapy
6%
Antifungal Therapy
6%
Diseases
6%